Early detection of COPD combined with individualized counselling for smoking cessation: A two-year prospective study

References

• Shirtcliffe P, Weatherall M, Marsh S, Travers J, Hansell A, McNaughton A, . COPD prevalence in a random population survey: A matter of definition. Eur Respir J 2007; 30:232–9.
   PubMed Web of Science ®Google Scholar
• Screening for chronic obstructive pulmonary disease using spirometry: US Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;148: 529–34.
   PubMed Web of Science ®Google Scholar
• Celli BR, MacNee W. Standards for the diagnosis and treatment of patients with COPD: A summary of the ATS/ERS position paper. Eur Respir J 2004;23:932–46.
   PubMed Web of Science ®Google Scholar
• Enright P. Does Screening for COPD by primary care physicians have the potential to cause more harm than good? Chest 2006;129:833–5.
   PubMed Web of Science ®Google Scholar
• Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 2006; 3:e442.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 2007;175:1222–32.
   PubMed Web of Science ®Google Scholar
• Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20:1117–22.
   PubMed Web of Science ®Google Scholar
• Johannessen A, Lehmann S, Omenaas ER, Eide GE, Bakke PS, Gulsvik A. Post-bronchodilator spirometry reference values in adults and implications for disease management. Am J Respir Crit Care Med 2006;173:1316–25.
   PubMed Web of Science ®Google Scholar
• Mannino DM, Sonia BA, Vollmer WM. Chronic obstructive pulmonary disease in the older adult: What defines abnormal lung function? Thorax 2007;62:237–41.
   PubMed Web of Science ®Google Scholar
• Hnizdo E, Glindmeyer HW, Petsonk EL, Enright P, Buist AS. Case definitions for chronic obstructive pulmonary disease. COPD 2006;3:95–100.
   PubMedGoogle Scholar
• Mannino DM. GOLD Stage 0 COPD: Is it real? Does it matter? Chest 2006;130:309–10.
   PubMed Web of Science ®Google Scholar
• Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Crit Care Med 2001;163:1256–76.
   PubMedGoogle Scholar
• Vestbo J, Lange P. Can GOLD Stage 0 provide information of prognostic value in chronic obstructive pulmonary disease? Am J Respir Crit Care Med 2002;166: 329–32.
   PubMed Web of Science ®Google Scholar
• Medbo A, Melbye H. What role may symptoms play in the diagnosis of airflow limitation? A study in an elderly population. Scand J Prim Health Care 2008;26: 92–8.
   PubMed Web of Science ®Google Scholar
• De Marco R, Accordini S, Cerveri I, Corsico A, Anto JM, Kunzli N, . Incidence of chronic obstructive pulmonary disease in a cohort of young adults according to the presence of chronic cough and phlegm. Am J Respir Crit Care Med 2007;175:32–9.
   PubMed Web of Science ®Google Scholar
• Ekberg-Aronsson M, Pehrsson K, Nilsson JA, Nilsson PM, Lofdahl CG. Mortality in GOLD stages of COPD and its dependence on symptoms of chronic bronchitis. Respir Res 2005;6:98.
   PubMed Web of Science ®Google Scholar
• Lindberg A, Jonsson AC, Ronmark E, Lundgren R, Larsson LG, Lundback B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest 2005;127:1544–52.
   PubMed Web of Science ®Google Scholar
• Van den Bemt L, Schermer T, van Weel C. Rational monitoring of COPD: Where do current clinical guidelines stand? Eur Respir J 2007;29:1078–81.
   PubMed Web of Science ®Google Scholar
• Goedhart DM, Zanen P, Lammers JW. Relevant and redundant lung function parameters in discriminating asthma from COPD. COPD 2006;3:33–9.
   PubMedGoogle Scholar
• Mannino DM, Buist AS. Global burden of COPD: Risk factors, prevalence, and future trends. Lancet 2007;370: 765–73.
   PubMed Web of Science ®Google Scholar
• Buffels J, Degryse J, Decramer M, Heyrman J. Spirometry and smoking cessation advice in general practice: A randomised clinical trial. Respir Med 2006;100:2012–17.
   PubMed Web of Science ®Google Scholar
• Bednarek M, Gorecka D, Wielgomas J, Czajkowska-Malinowska M, Regula J, Mieszko-Filipczyk G, . Smokers with airway obstruction are more likely to quit smoking. Thorax 2006;61:869–73.
   PubMed Web of Science ®Google Scholar
• Gorecka D, Bednarek M, Nowinski A, Puscinska E, Goljan-Geremek A, Zielinski J. Diagnosis of airflow limitation combined with smoking cessation advice increases stop-smoking rate. Chest 2003;123:1916–23.
   PubMed Web of Science ®Google Scholar
• Stratelis G, Molstad S, Jakobsson P, Zetterstrom O. The impact of repeated spirometry and smoking cessation advice on smokers with mild COPD. Scand J Prim Health Care 2006;24:133–9.
   PubMed Web of Science ®Google Scholar
• Kotz D, van Schayck CP, Huibers MJ, Wesseling GJ. Assessing the efficacy of spirometry for smoking cessation. Thorax 2007;62:74.
   Google Scholar
• Kotaniemi J-T, Sovijarvi A, Lundback B. Chronic obstructive pulmonary disease in Finland: Prevalence and risk factors. COPD 2005;2:331–9.
   PubMedGoogle Scholar
• Dunn C, Deroo L, Rivara FP. The use of brief interventions adapted from Motivational Interviewing across behavioral domains: A systematic review. Addiction 2001;96: 1725–42.
   PubMed Web of Science ®Google Scholar
• Lancaster T, Stead LF. Individual behavioural counselling for smoking cessation. Cochrane Database Syst Rev 2000: CD001292.
   Google Scholar
• Viljanen AA, Halttunen PK, Kreus KE, Viljanen BC. Spirometric studies in non-smoking, healthy adults. Scand J Clin Lab Invest Suppl 1982;159:5–20.
   PubMedGoogle Scholar
• Stratelis G, Fransson SG, Schmekel B, Jakobsson P, Molstad S. High prevalence of emphysema and its association with BMI: A study of smokers with normal spirometry. Scand J Prim Health Care 2008;26:241–7.
   PubMed Web of Science ®Google Scholar
• Rytila P, Helin T, Kinnula V. The use of microspirometry in detecting lowered FEV1 values in current or former cigarette smokers. Prim Care Respir J 2008;17:232–7.
   PubMedGoogle Scholar
• Stratelis G, Jakobsson P, Molstad S, Zetterstrom O. Early detection of COPD in primary care: Screening by invitation of smokers aged 40 to 55 years. Br J Gen Pract 2004;54: 201–6.
   PubMed Web of Science ®Google Scholar
• Van Schayck CP, Chavannes NH. Detection of asthma and chronic obstructive pulmonary disease in primary care. Eur Respir J Suppl 2003;39:16s–22s.
   Google Scholar
• Zielinski J, Bednarek M. Early detection of COPD in a high-risk population using spirometric screening. Chest 2001; 119:731–6.
   PubMed Web of Science ®Google Scholar
• Bridevaux PO, Gerbase MW, Probst-Hensch NM, Schindler C, Gaspoz JM, Rochat T. Long-term decline in lung function, utilisation of care and quality of life in modified GOLD Stage 1 COPD. Thorax 2008;63:768–74.
   PubMed Web of Science ®Google Scholar
• Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1: The Lung Health Study. JAMA 1994;272:1497–1505.
   PubMed Web of Science ®Google Scholar
• Strassmann R, Bausch B, Spaar A, Kleijnen J, Braendli O, Puhan MA. Smoking cessation interventions in COPD: A network meta-analysis of randomised trials. Eur Respir J 2009;34:634–40.
   PubMed Web of Science ®Google Scholar
• Hajek P, Stead LF, West R, Jarvis M, Lancaster T. Relapse prevention interventions for smoking cessation. Cochrane Database Syst Rev 2009:CD003999.
   Google Scholar